Skip to main content

$0.077 -0.003 (-3.75%)

High

$0.08

Low

$0.08

Trades

6

Turnover

$17,007

Volume

211,355
30 June 2023 at 1:01pm
Register to track PEB and receive email alerts.
Subject
PEB Ann: Notice of Annual General Meeting/Proxy Form

PEB Ann: Annual Report to shareholders

PEB Article: ASX slips; Goldman forecasts cash rate to peak at 4.85pc

PEB Article: Pacific Edge slumps 71pc on US Medicare rejection

PEB Article: ASX edges up; Goldman forecasts cash rate to peak at 4.85pc

PEB Article: ASX flat; yield curve inverts, flashes recession signal

PEB Ann: Medicare Coverage of Cxbladder Expected to Cease

PEB Ann: Pacific Edge Trading Halt

PEB Ann: Trading Halt

PEB Ann: Clarification of Novitas Timeline

PEB Ann: Pacific Edge Delivers on Growth Strategy in FY 2023

PEB Ann: Director Nomination Closing Date

PEB Ann: Notification regarding unquoted securities - PEB

PEB Ann: Capital Change Notice - NZX

PEB Ann: Pacific Edge Full Year Result to be Announced 25 May 2023

PEB Ann: Quarterly Update Q4 23 Test Volumes Reach New Record

PEB Ann: Pacific Edge Provides Update on Kaiser EMR Integration

PEB Ann: Quarterly Investor Update - Q3 FY23 Test Volumes rise 36%

PEB Ann: Te Whatu Ora - Southern Commercial Agreement Completed

PEB Ann: Notification regarding unquoted securities - PEB

PEB Ann: Application for quotation of securities - PEB

PEB Ann: Notification of cessation of securities - PEB

PEB Ann: NZX D&O Disclosures - P Meintjes & G Gibson

PEB Ann: Capital Change Notice - NXZ

PEB Ann: Capital Change Notice - NZX

PEB Ann: Enhanced Cxb Tests Deliver Improved Diagnostic Performance

PEB Ann: Financial Results for the Half Year to 30 September 2022

PEB Ann: Interim Financial Results to be Announced 24 November 2022

PEB Ann: Quarterly Investor Update - Q2 FY23 Test Volumes rise 36%

PEB Ann: Letter to Shareholders

PEB Ann: Update on Te Whatu Ora Southern Commercial Agreement

PEB Ann: PACIFIC EDGE COMMENTS ON PROPOSED NOVITAS LCD

PEB Ann: Trading Halt

PEB Ann: Pause in Trading

PEB Ann: Pacific Edge 2022 Annual Shareholders Meeting - Results

PEB Ann: Pacific Edge 2022 Annual Shareholders Meeting

PEB Ann: Pacific Edge Appoints Chief Operating Officer

PEB Ann: Southern District Health Region Adopts Cxbladder Tests

PEB Ann: Pacific Edge Investor Update - Q1 FY23 Test Volumes Rise 32%

PEB Ann: Notice of Annual General Meeting/Proxy Form

PEB Ann: Annual Report to shareholders

PEB Ann: Kaiser Permanente agrees to Cxbladder EMR Integration

PEB Ann: Pacific Edge LTD FY22 Result

PEB Ann: PEB FY22 Result - NZX Announcement Template

PEB Ann: Director Nomination Closing Date

PEB Ann: Clinical Study Advancing Cxbladder as standard of care

PEB Ann: Pacific Edge Full Year Result to be Announced 26 May 2022

PEB Ann: D&O Disclosure - NZX - D Darling

PEB Ann: Capital Change Notice - NZX

PEB Ann: Application for quotation of securities - PEB

Register to track PEB and receive email alerts.